Koninklijke Philips N.V. NY Registry Shares Stock 12‑Month Price Target Cut to $31.6, Implies 26% Upside

Analyst estimates cited by FactSet show Koninklijke Philips N.V. NY Registry Shares’ average 12-month price target was cut to $31.6 from $31.78. The new range is $25.73 to $37.57, implying about 26% upside versus the Jul. 27 close. Consensus remains “Buy” with 10 Buys, 11 Holds, and 0 Sells.

Original reporting
Published Jul 28, 2026, 10:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 6:13 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Koninklijke Philips N.V. NY Registry Shares Stock 12‑Month Price Target Cut to $31.6, Implies 26% Upside — source image
Decision brief

The 30-second read

$PHGNeutralLow
01

Why it matters

The key actionable element is the revised consensus target (down slightly) while maintaining a “Buy” consensus, which may affect short-term positioning but does not introduce new company-specific fundamentals.

02

Market read

Traders may see minor sentiment impact from the target reduction, but the unchanged “Buy” consensus limits directional conviction.

03

What to watch

Analyst target changes can lag new information; without details on the rationale for the cut, traders should treat it as sentiment noise until the underlying thesis is updated.

Relevance 4/10Novelty 4/10Timing: after-hours/late-day analyst target update (published 2026-07-28)

Background

The piece summarizes FactSet-derived analyst consensus for Koninklijke Philips, focusing on the updated average price target and the distribution of ratings.

Company-level read

Ticker impact

$PHGNeutralMedium confidence
Context

Philips’ average analyst price target fell from $31.78 to $31.6, with a $25.73 to $37.57 range, implying ~26% upside from the Jul. 27 close.

Expected impact

Likely modest, sentiment-driven volatility rather than a sustained repricing unless follow-on analyst actions or new company fundamentals emerge.

Evidence & confidence

The article reports a revised consensus target and unchanged “Buy” consensus mix, with no new operational, financial, or regulatory facts beyond the target update.

Market effects

Limited sector read-through because the update is confined to a single company’s analyst target consensus.

No clear regional spillover beyond European healthcare/medical equipment sentiment.

Mostly company-specific sentiment; no broader macro or cross-asset catalyst mentioned.

Counterpoint

The target cut could signal growing caution on fundamentals, and the implied upside may be overstated if the market already prices the consensus view.

Key entities

  • Koninklijke Philips N.V. NY Registry Shares

    Analyst consensus price target cut to $31.6, with forecasts from $25.73 to $37.57 and “Buy” consensus unchanged.

Related articles

$PHGMed

Philips Gets a Tariff Refund, Not a Clean Bill of Health

Philips reported Q2 sales of €4.4B (up 4% comparable) and an adjusted EBITA margin of 16.4%. The company said a €186M US tariff refund drove most of the margin improvement, while underlying margin fell. Orders were down 1% comparable, with some North America Connected Care contracts delayed. Full-year sales guidance was unchanged; margin and free cash flow guidance were raised.

$PHGMed

Philips Stock Falls 9% as Weak Orders Overshadow Outlook

Philips (PHG) shares fell about 9% in European trading after the company reported weaker-than-expected orders and warned that conditions in China are getting harder. Philips said comparable order intake fell 1% mainly due to delays in closing large U.S. contracts. It kept an improved full-year profitability outlook but expects third-quarter adjusted EBITDA margin below last year.

$PHGMedAI 8/10

Philips beats Q2 profit estimates due to tariff refunds

Philips reported Q2 adjusted EBITA margin of 16.4%, above analysts’ 12.1% forecast, helped by US tariff refunds. The company said it largely completed the refund process during the quarter. Philips raised its 2026 outlook to an adjusted EBITA margin of 13.5%-14% (from 12.5%-13%) and forecast free cash flow of €1.5-1.7 billion. Sales rose 4% to €4.4 billion.